From Brand Collecting to Focused Portfolios
Beauty company acquisitions are shifting from broad brand collecting toward tight, selective portfolio management, where groups shed non-core assets and double down on a few scalable, high-potential franchises. This portfolio consolidation trend reflects a move away from sprawling brand stables toward clearer category leadership, higher marketing focus and deeper investment behind winners instead of spreading capital across many small bets. Historically, cosmetics M&A trends rewarded companies that bought into every adjacent niche, but that model is under pressure as growth slows, financing tightens and competition intensifies. Today’s makeup brand portfolio strategy increasingly starts with a simple question: which brands can meaningfully lead in their segment, and which distract management and dilute resources? The answers are driving both divestiture and targeted control deals as companies redefine what a “platform” should look like in the next phase of the beauty market.
Waldencast’s Obagi Exit: Cashing In to Back Milk Makeup
Waldencast’s decision to sell Obagi Medical for US$460m (approx. RM2,116m) to Bridgepoint is a clear example of brand divestiture strategy used to sharpen focus. The deal will leave Waldencast centered on one priority asset: Milk Makeup, spanning make-up and skin care. Waldencast, formed as a SPAC in 2021, had acquired both Obagi Medical and Milk Makeup in 2022 in a platform-style push. A few years on, a strategic review led the board to a different conclusion: simplify, pay down debt and channel investment into a single high-growth, consumer-facing brand. According to Waldencast chairman Felipe Dutra, the sale both strengthens the company’s balance sheet and “enables a sharper strategic focus on Milk Makeup, a brand with significant global growth potential.” In portfolio terms, this is a pivot away from physician-led dermatology toward consumer color and hybrid beauty, with capital and leadership aligned behind one flagship.
Proya and Flower Knows: Going Deeper in Color Cosmetics
While some groups are selling to simplify, others are making tightly targeted buys. Proya’s move to take a controlling 51% stake in Flower Knows aims to deepen, not diversify, its color cosmetics position. The company purchased an additional 12.6% from shareholder Yang Zifeng for CNY351 million, consolidating Flower Knows into its financial results and elevating it as Proya’s second-largest cosmetics brand after generating CNY1.7 billion in revenue and CNY280 million in net profit last year. Rather than chase unrelated categories, Proya is using M&A to strengthen a segment where it already sees momentum: its makeup brands, including Timage and Insbaha, have been growing even as its core skincare business slows. This is a different kind of beauty company acquisition strategy—less about category sprawl, more about owning a bigger share of a single, strategically important arena like color cosmetics.
Why Fewer Brands Can Mean More Growth
These moves point to a broader rethinking of what makes a beauty platform effective. A tighter makeup brand portfolio strategy frees cash and management time to support priority brands with heavier marketing, faster innovation cycles and more aggressive market penetration. For groups like Waldencast, exiting Obagi and related assets reduces leverage and removes the need to balance very different business models, from medical aesthetics to consumer color. For Proya, consolidating Flower Knows helps it scale one of its strongest growth engines, rather than spreading resources thin across many smaller labels. In both cases, cosmetics M&A trends are less about empire-building and more about clarity: own brands that align with core capabilities, and let go of those that do not. Fewer brands can mean bigger bets per brand, stronger consumer awareness and cleaner growth stories for investors.